Roivant Sciences Ltd.
Symbol: ROIV
NASDAQ
11.25
USDTržní cena dnes
2.0826
Poměr P/E
0.0316
Poměr PEG
9.07B
MRK Cap
- 0.00%
Výnos DIV
Roivant Sciences Ltd. (ROIV) finanční výkazy
Rozvaha
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1692.1 | 2074 | 2055 | |||||
balance-sheet.row.short-term-investments | 0 | 15.3 | 13.6 | 0 | |||||
balance-sheet.row.net-receivables | 0 | 32.7 | 6.7 | 13.8 | |||||
balance-sheet.row.inventory | 0 | 2.8 | -16.5 | 63.9 | |||||
balance-sheet.row.other-current-assets | 0 | 121.8 | 82.2 | 54.3 | |||||
balance-sheet.row.total-current-assets | 0 | 1798.6 | 2146.5 | 2187 | |||||
balance-sheet.row.property-plant-equipment-net | 0 | 92.3 | 86.9 | 77 | |||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.intangible-assets | 0 | 144.9 | 0 | 0 | |||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 144.9 | 0 | 0 | |||||
balance-sheet.row.long-term-investments | 0 | 304.3 | 325.8 | 289.5 | |||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.other-non-current-assets | 0 | 49.5 | 25.8 | 36.1 | |||||
balance-sheet.row.total-non-current-assets | 0 | 591 | 438.6 | 402.7 | |||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.total-assets | 0 | 2389.6 | 2585.1 | 2589.7 | |||||
balance-sheet.row.account-payables | 0 | 37.8 | 34.6 | 20.6 | |||||
balance-sheet.row.short-term-debt | 0 | 52.4 | 11.4 | 12.3 | |||||
balance-sheet.row.tax-payables | 0 | 0.5 | 0.7 | 0.2 | |||||
balance-sheet.row.long-term-debt-total | 0 | 429 | 272.5 | 232.7 | |||||
Deferred Revenue Non Current | 0 | 0 | 13.7 | 0 | |||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||
balance-sheet.row.other-current-liab | 0 | 15.1 | 128.2 | 180.2 | |||||
balance-sheet.row.total-non-current-liabilities | 0 | 509.6 | 339.3 | 308.7 | |||||
balance-sheet.row.other-liabilities | 0 | 0 | 22.5 | 0 | |||||
balance-sheet.row.capital-lease-obligations | 0 | 65.2 | 73.9 | 74.7 | |||||
balance-sheet.row.total-liab | 0 | 782 | 546.2 | 527.7 | |||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.common-stock | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.retained-earnings | 0 | -3772.8 | -2763.7 | -1918.5 | |||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -2.6 | -0.9 | 1.4 | |||||
balance-sheet.row.other-total-stockholders-equity | 0 | 5383 | 4803.6 | 3714.8 | |||||
balance-sheet.row.total-stockholders-equity | 0 | 1607.6 | 2038.9 | 1797.8 | |||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 2389.6 | 2585.1 | 2589.7 | |||||
balance-sheet.row.minority-interest | 0 | 449.8 | 404.5 | 264.2 | |||||
balance-sheet.row.total-equity | 0 | 2057.4 | 2443.4 | 2062 | |||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||
Total Investments | 0 | 304.3 | 325.8 | 289.5 | |||||
balance-sheet.row.total-debt | 0 | 481.4 | 283.9 | 245 | |||||
balance-sheet.row.net-debt | 0 | -1195.4 | -1776.5 | -1810.1 |
Výkaz peněžních toků
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -1115.5 | -924.1 | -900.2 | |||||
cash-flows.row.depreciation-and-amortization | 0 | 18.9 | 5.9 | 0 | |||||
cash-flows.row.deferred-income-tax | 0 | -4.4 | -5.9 | 0 | |||||
cash-flows.row.stock-based-compensation | 0 | 217.8 | 565 | 85 | |||||
cash-flows.row.change-in-working-capital | 0 | 6.3 | 15.7 | 71.9 | |||||
cash-flows.row.account-receivables | 0 | 0 | 0 | 0 | |||||
cash-flows.row.inventory | 0 | 0 | 0 | 0 | |||||
cash-flows.row.account-payables | 0 | 4.4 | 15.4 | 3.8 | |||||
cash-flows.row.other-working-capital | 0 | 2 | 0.3 | 68.2 | |||||
cash-flows.row.other-non-cash-items | 0 | 33.4 | -334.3 | 191.2 | |||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -12.7 | -17.4 | -5.8 | |||||
cash-flows.row.acquisitions-net | 0 | 107.9 | 0 | 0 | |||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | -28.3 | |||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 320.2 | 0 | |||||
cash-flows.row.other-investing-activites | 0 | -139.4 | 0.6 | 2.4 | |||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -44.3 | 303.3 | -31.7 | |||||
cash-flows.row.debt-repayment | 0 | -30.1 | -21.6 | 0 | |||||
cash-flows.row.common-stock-issued | 0 | 379.7 | 313.4 | 455.8 | |||||
cash-flows.row.common-stock-repurchased | 0 | 0.3 | 0 | -0.1 | |||||
cash-flows.row.dividends-paid | 0 | -162.7 | 0 | 0 | |||||
cash-flows.row.other-financing-activites | 0 | 312.3 | 15 | 0.6 | |||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 499.5 | 306.8 | 456.3 | |||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 6.3 | 0 | 0 | |||||
cash-flows.row.net-change-in-cash | 0 | -381.9 | -67.6 | -127.6 | |||||
cash-flows.row.cash-at-end-of-period | 0 | 1692.1 | 2074 | 2141.7 | |||||
cash-flows.row.cash-at-beginning-of-period | 0 | 2074 | 2141.7 | 2269.3 | |||||
cash-flows.row.operating-cash-flow | 0 | -843.4 | -677.7 | -552.1 | |||||
cash-flows.row.capital-expenditure | 0 | -12.7 | -17.4 | -5.8 | |||||
cash-flows.row.free-cash-flow | 0 | -856.1 | -695.2 | -557.9 |
Řádek výkazu zisku a ztráty
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 61.3 | 55.3 | 23.8 | |||||
income-statement-row.row.cost-of-revenue | 0 | 13.1 | 9 | 2.1 | |||||
income-statement-row.row.gross-profit | 0 | 48.2 | 46.3 | 21.7 | |||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||
income-statement-row.row.research-development | 0 | - | - | - | |||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.other-expenses | 0 | -62.2 | -0.1 | -33.4 | |||||
income-statement-row.row.operating-expenses | 0 | 1125.7 | 1258.1 | 496.5 | |||||
income-statement-row.row.cost-and-expenses | 0 | 1138.8 | 1267 | 498.6 | |||||
income-statement-row.row.interest-income | 0 | 32.2 | 0.4 | 1.4 | |||||
income-statement-row.row.interest-expense | 0 | 28 | 7 | 2.8 | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.total-other-income-expensenet | 0 | -147.3 | 288 | 172.4 | |||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||
income-statement-row.row.other-operating-expenses | 0 | -62.2 | -0.1 | -33.4 | |||||
income-statement-row.row.total-operating-expenses | 0 | -147.3 | 288 | 172.4 | |||||
income-statement-row.row.interest-expense | 0 | 28 | 7 | 2.8 | |||||
income-statement-row.row.depreciation-and-amortization | 0 | -30 | -288.1 | 560.4 | |||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||
income-statement-row.row.operating-income | 0 | -1077.6 | -1211.7 | -1070.9 | |||||
income-statement-row.row.income-before-tax | 0 | -1224.8 | -923.7 | -898.5 | |||||
income-statement-row.row.income-tax-expense | 0 | 5.2 | 0.4 | 1.7 | |||||
income-statement-row.row.net-income | 0 | -1230 | -924.1 | -900.2 |
Často kladené otázky
Co je Roivant Sciences Ltd. (ROIV) celková aktiva?
Roivant Sciences Ltd. (ROIV) celková aktiva jsou 2389604000.000.
Jaký je roční obrat podniku?
Roční příjmy jsou N/A.
Jaké je ziskové rozpětí podniku?
Zisková marže firmy je 0.876.
Jaký je volný peněžní tok podniku?
Volný peněžní tok je -1.047.
Jaká je čistá zisková marže podniku?
Čistá zisková marže je 35.091.
Jaké jsou celkové tržby podniku?
Celkové příjmy jsou 39.165.
Co je Roivant Sciences Ltd. (ROIV) čistý zisk (čistý příjem)?
Čistý zisk (čistý příjem) je -1230024000.000.
Jaký je celkový dluh podniku?
Celkový dluh je 481404000.000.
Jaké je číslo provozních nákladů?
Provozní výdaje jsou 1125721000.000.
Jaké je číslo peněžních prostředků firmy?
Peněžní prostředky podniku jsou 0.000.